Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

NCT06401889 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT06401889
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401889 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Recruiting
Start date
July 19, 2024
Completion date
July 19, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anatomic stage 0 breast cancer ajcc v8, anatomic stage i breast cancer ajcc v8, anatomic stage ii breast cancer ajcc v8, anatomic stage iii breast cancer ajcc v8, breast adenocarcinoma, estrogen receptor-positive breast carcinoma, progesterone receptor-positive breast carcinoma